About Pulse Pharma Private Limited
Data last updated:
Pulse Pharma Private Limited is a private limited company based in New, Delhi, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 31 January 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1995PTC064858. Its GSTIN is 07AAACP7399C1Z9 (Delhi).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹79.5 Lakh. It is led by directors Jyoti Bahri and Deepak Bahri.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 212 Ashirwad Commercial Complex D – 1 Green Park, New, Delhi, India – 110016.
As per the financials filed for FY 2025, the company reported a revenue of ₹61.23 Lakh, a decline of 46% compared to the previous year. For the same year it recorded a net loss of ₹8.48 Lakh (net margin -13.9%) and EBITDA of ₹30.19 Lakh (EBITDA margin 49.3%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 4% over five years.
The company has about 3 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Pulse Medika. As per MCA filings, the company has satisfied charges of ₹371.63 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pulsemedika.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address212 Ashirwad Commercial Complex D – 1 Green Park, New, Delhi, India – 110016
- IndustryHealthcare, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Pulse Pharma Private Limited
The main business activity of Pulse Pharma is manufacturing. In detail, this covers other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Pulse Pharma Private Limited FY 2025 filings available
Pulse Pharma Private Limited reported revenue of ₹61.23 Lakh (down 46% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Pulse Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 46% fall in the latest year. EBITDA fell 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Pulse Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹30.19 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹8.48 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Pulse Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 49.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -13.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pulse Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Pulse Pharma Private Limited
Pulse Pharma Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Medical and Laboratory Equipment). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Innodx Solutions Private Limited | ₹61.6 Lakh (FY 2024) | •••• | •••• | 45.0% | •••• | Sadar Bazar, Haryana, India |
| Greenocean Research Labs Private Limited | ₹61.57 Lakh (FY 2024) | •••• | •••• | -40.0% | •••• | Chennai, Tamil Nadu, India |
| Mbgenesis Healthcare Private Limited | ₹61.54 Lakh (FY 2022) | •••• | •••• | -38.0% | •••• | Pune, Maharashtra, India |
| Lifetrons Inno Equipments Private Limited | ₹61.49 Lakh (FY 2025) | •••• | •••• | 375.0% | •••• | Hubli, Karnataka, India |
| Delta Scientific Equipment Pvt Ltd | ₹61.42 Lakh (FY 2024) | •••• | •••• | -34.0% | •••• | Kolkata, West Bengal, India |
| Pulse Pharma Private Limited this company | ₹61.23 Lakh (FY 2025) | •••• | •••• | -46.0% | •••• | New Delhi, Delhi, India |
| Devilbiss Healthcare Private Limited | ₹61.18 Lakh (FY 2024) | •••• | •••• | -56.0% | •••• | Mumbai, Maharashtra, India |
| Amixor Pharmaceuticals Private Limited | ₹61.11 Lakh (FY 2025) | •••• | •••• | 17.0% | •••• | Mhow, Madhya Pradesh, India |
| Baby Essentials Private Limited | ₹61 Lakh (FY 2024) | •••• | •••• | 48.0% | •••• | Faridabad, Haryana, India |
| Sure Image Technologies Private Limited | ₹61 Lakh (FY 2020) | •••• | •••• | •••• | Panipat, Haryana, India | |
| Maayug Surgicals Private Limited | ₹60.9 Lakh (FY 2022) | •••• | •••• | 151706.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Pulse Pharma by revenue in the Healthcare industry (Medical and Laboratory Equipment), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Pulse Pharma Private Limited
Pulse Pharma Private Limited is audited by R.R. Sharma & Co. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R.R. Sharma & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Pulse Pharma Private Limited
Pulse Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jyoti Bahri Also directs: Rubicon Securities Private Limited | Director | 31 Jan 1995 | 31 Years 8 Months | Current |
| Deepak Bahri | Director | 31 Jan 1995 | 31 Years 8 Months | Current |
Ownership and Shareholding of Pulse Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pulse Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jun 2012 | Citibank N.A | ₹7 Cr | Satisfied |
| 23 Aug 2008 | Canara Bank | ₹130.99 Cr | Satisfied |
| 16 May 2006 | Icici Bank Limited | ₹28.34 Cr | Satisfied |
| 03 Nov 2005 | Canara Bank | ₹102.65 Cr | Satisfied |
| 29 Sep 1999 | Canara Bank | ₹102.65 Cr | Satisfied |
Total charge records: 5 View all charges
Legal Cases of Pulse Pharma Private Limited
Pulse Pharma Private Limited has 1 court case on record: 1 filed by Pulse Pharma. All case is disposed. Status as checked on 01 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North East, Delhi | Execution petition | Filed by the company against an individual | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Pulse Pharma Private Limited
Pulse Pharma operates one associated brand: Pulse Medika. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Distributor of medical equipment | pulsemedika.com |
Employees and EPFO Compliance at Pulse Pharma Private Limited
Pulse Pharma Private Limited has a workforce of 3 employees as of Apr 01, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Pulse Pharma Private Limited
Pulse Pharma Private Limited has 4 board changes on record since 1995: 2 appointments and 2 cessations. The latest: Rama Kant Sharma ceased to be Director on 07 Dec 2021.
9 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Pulse Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pulse Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pulse Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pulse Pharma Private Limited
Pulse Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACP7399C1Z9 | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pulse Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pulse Pharma Private Limited
Pulse Pharma is an active private limited company based in New, Delhi, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 31 January 1995 (31+ years old) and is registered under CIN U74899DL1995PTC064858.
Pulse Pharma reported revenue of ₹61.23 Lakh for FY 2025 (down 46% YoY).
Pulse Pharma has 2 current directors:
- Jyoti Bahri - Director
- Deepak Bahri - Director
Pulse Pharma reported a net loss of ₹8.48 Lakh (net margin -13.9%) and EBITDA of ₹30.19 Lakh (EBITDA margin 49.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Pulse Pharma is -2% over three years and -4% over five years. In the latest year (FY 2025) revenue fell 46%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Pulse Pharma is 07AAACP7399C1Z9, registered in Delhi.
The CIN (Corporate Identification Number) of Pulse Pharma is U74899DL1995PTC064858. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pulse Pharma has 1 court case on record: 1 filed by the company.
Pulse Pharma was incorporated on 31 January 1995, making it 31+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Pulse Pharma by revenue are Innodx Solutions Private Limited, Greenocean Research Labs Private Limited, Mbgenesis Healthcare Private Limited, Lifetrons Inno Equipments Private Limited, Delta Scientific Equipment Pvt Ltd and 5 more, all in the Healthcare industry (Medical and Laboratory Equipment).
Rama Kant Sharma ceased to be Director on 07 Dec 2021. Bantwal Raghurama Prabhu ceased to be Director on 12 Oct 2014. Deepak Bahri was appointed as Director on 31 Jan 1995. Pulse Pharma has 4 board changes on record in total.